Within the last 5 years, efforts to stratify and optimise glioblastoma patients for predicted responses to therapy by Yin, Prasad, Yu and colleagues independently identified IGFBP-2 in gene signatures (with under 20 genes) associated with worse outcomes [212,213,214]. The gene discussed is IGFBP2; the disease is glioblastoma.